207 related articles for article (PubMed ID: 34158394)
21. Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.
Bartella V; Rizza P; Barone I; Zito D; Giordano F; Giordano C; Catalano S; Mauro L; Sisci D; Panno ML; Fuqua SA; Andò S
Breast Cancer Res Treat; 2012 Jul; 134(2):569-81. PubMed ID: 22622808
[TBL] [Abstract][Full Text] [Related]
22. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
[TBL] [Abstract][Full Text] [Related]
23. Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.
Jonsson P; Coarfa C; Mesmar F; Raz T; Rajapakshe K; Thompson JF; Gunaratne PH; Williams C
Mol Endocrinol; 2015 Nov; 29(11):1634-45. PubMed ID: 26426411
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
[TBL] [Abstract][Full Text] [Related]
25. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
Lee JY; Park YJ; Oh N; Kwack KB; Park KS
Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
[TBL] [Abstract][Full Text] [Related]
26. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
Wang C; Mayer JA; Mazumdar A; Brown PH
Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
[TBL] [Abstract][Full Text] [Related]
27. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
Magnani L; Ballantyne EB; Zhang X; Lupien M
PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
[TBL] [Abstract][Full Text] [Related]
28. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
29. Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.
Tan Y; Jin C; Ma W; Hu Y; Tanasa B; Oh S; Gamliel A; Ma Q; Yao L; Zhang J; Ohgi K; Liu W; Aggarwal AK; Rosenfeld MG
Mol Cell; 2018 Aug; 71(4):526-539.e8. PubMed ID: 30118678
[TBL] [Abstract][Full Text] [Related]
30. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
[TBL] [Abstract][Full Text] [Related]
31. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
[TBL] [Abstract][Full Text] [Related]
32. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
[TBL] [Abstract][Full Text] [Related]
33. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
34. Estrogen enhances the cytotoxicity of PARP inhibitors on breast cancer cells through stimulating nitric oxide production.
Zhou S; Liu Y; Jin L; Guo P; Liu Q; Shan J; Luo X; He H; Ma W; Zhang T
J Steroid Biochem Mol Biol; 2021 May; 209():105853. PubMed ID: 33617965
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
[TBL] [Abstract][Full Text] [Related]
36. Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.
Sengupta S; Biarnes MC; Jordan VC
Breast Cancer Res Treat; 2014 Jan; 143(1):113-24. PubMed ID: 24309997
[TBL] [Abstract][Full Text] [Related]
37. PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells.
Rasmussen M; Tan S; Somisetty VS; Hutin D; Olafsen NE; Moen A; Anonsen JH; Grant DM; Matthews J
Cells; 2021 Mar; 10(3):. PubMed ID: 33799807
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
39. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.
Bretschneider N; Brand H; Miller N; Lowery AJ; Kerin MJ; Gannon F; Denger S
Cancer Res; 2008 Jan; 68(1):106-14. PubMed ID: 18172302
[TBL] [Abstract][Full Text] [Related]
40. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]